State-of-art review: intravascular imaging in percutaneous coronary interventions [0.03%]
血管内影像在经皮冠状动脉介入治疗中的现状回顾
Tarek Nafee,Areeb Shah,Michael Forsberg et al.
Tarek Nafee et al.
The history of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) reflects the relentless pursuit of innovation in interventional cardiology. These intravascular imaging technologies have played a pivotal role in our und...
Ling Leng,Xiu-Wu Bian
Ling Leng
Heart dysfunction is one of the most life-threatening organ dysfunctions caused by coronavirus disease 2019 (COVID-19). Myocardial or cardiovascular damage is the most common extrapulmonary organ complication in critically ill patients. Und...
All-cause mortality in moderate and severe COVID-19 patients with myocardial injury receiving versus not receiving azvudine: a propensity score-matched analysis [0.03%]
阿兹夫定用于新冠病毒感染合并心肌损伤患者的疗效及安全性：倾向性评分匹配分析
Ru Chen,Yi Guo,Shan Deng et al.
Ru Chen et al.
Omicron is currently the dominant strain of severe acute respiratory syndrome coronavirus 2, but little is known about the characteristics and management of omicron related myocardial injury, particularly the potential benefit of the antivi...
COVID-19 infection with complicated fulminant myocarditis: a case report [0.03%]
新型冠状病毒感染合并暴发性心肌炎一例报告
Kun Miao,Jinsheng Lai,Feng Wang et al.
Kun Miao et al.
Herein, we report the case of a young female patient who suffered from myositis and heart failure due to fulminant myocarditis induced by the 2019 coronavirus disease (COVID-19). After receiving intra-aortic balloon pump (IABP) and immunomo...
Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies [0.03%]
新冠肺炎相关心肌炎的病理生理、诊断和治疗策略理解
Hongyang Shu,Chunxia Zhao,Dao Wen Wang
Hongyang Shu
Coronavirus disease 2019 (COVID-19) disease has infected nearly 600 million people, resulting in > 6 million deaths, with many of them dying from cardiovascular diseases. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectio...
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases [0.03%]
2023年COVID-19对心血管疾病管理影响的中国专家共识
Feng Bai,Jun Pu,Wenliang Che et al.
Feng Bai et al.
The primary site of infection in COVID-19 exhibit is the respiratory system, but multiple organ systems could be affected. The virus could directly invade cardiomyocytes. Alternatively, cytokine storm could lead to myocardial injury. More i...
Metabolism, inflammation, and cardiovascular diseases from basic research to clinical practice [0.03%]
代谢、炎症与心血管疾病：从基础研究到临床实践
Zihang Huang,Aijun Sun
Zihang Huang
Effect of in-hospital evolocumab therapy on lipoprotein(a) in patients with acute myocardial infarction: a retrospective cohort study and a propensity score matching analysis [0.03%]
依折麦布对急性心肌梗死患者低密度脂蛋白a的影响：基于回顾性队列研究和倾向性评分匹配分析的结果
Ge Gao,Tao Zheng,Beidi Lan et al.
Ge Gao et al.
Elevated lipoprotein(a) is associated with an increased risk of atherosclerotic cardiovascular disease. Evolocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, has been shown to reduce lipoprotein(a). However, the effect of e...
Erratum to Stretococcus gallolyticus infective endocarditis, a different presentation-a case report [0.03%]
肠球菌感染性心内膜炎的另一种表现形式——个案报告的勘误通知
Cardiology Plus Editorial Office*
Cardiology Plus Editorial Office*
[This corrects the article DOI: 10.1097/CP9.0000000000000020.]. Copyright © 2023 China Heart House.
Published Erratum
Cardiology plus. 2023 Jan-Mar;8(1):67. DOI:10.1097/CP9.0000000000000045 2023
Identification of the metabolic state of surviving cardiomyocytes in the human infarcted heart by spatial single-cell transcriptomics [0.03%]
基于空间单细胞转录组学识别人类心肌梗死心脏中存活心肌细胞的代谢状态
Yan Shen,Il-Man Kim,Neal L Weintraub et al.
Yan Shen et al.
The metabolic status of surviving cardiomyocytes (CM) in the myocardial tissues of patients who sustained myocardial infarction (MI) is largely unknown. Spatial single-cell RNA-sequencing (scRNA-seq) is a novel tool that enables the unbiase...